Cme Group Inc. · NASDAQ:CME
Cme — Q1 2025 Earnings Presentation
9 slides from Cme's earnings presentation, Apr 23, 2025
Slide 1: 1Q 2025 Earnings Commentary
1Q 2025 Earnings Commentary Revenue (millions) Adjusted 1Q 2025 Summary Adjusted Operating Diluted EPS CME Group’s strong performance in 1Q25 is evidence of our Expense (millions) clients’ ever-growing need for risk management driving our highest ever revenue, as well as record operating income, net
Slide 2: 1Q 2025 Highlights & Commentary
1Q 2025 Earnings Commentary - Unaudited 1Q 2025 Highlights & Commentary (ADV,OI stated in contracts) Significant, broad-based activity during the quarter helped to deliver all-time high revenue, as well as record operating income, net income and diluted EPS on an adjusted basis ● 1Q 2025 ADV up 13%
Slide 3: Record non-U.S. ADV; Financials and Interest Rates results
1Q 2025 Earnings Commentary - Unaudited All-time high quarterly non-U.S. ADV of 8.8 million contracts, up 19% and including records for EMEA and APAC as well as double-digit YoY growth across all six asset classes ● Record EMEA region ADV of 6.5 million, up Non-U.S. ADV (millions) 20%, and including
Slide 4: FX and Commodities driving growth
1Q 2025 Earnings Commentary - Unaudited 1Q FX ADV increased 17% to a record 1.1 million Annual FX F&O ADV 1.1 ● Euro FX futures increased 17% to 301K ● Japanese Yen futures increased 11% to 194K ADV millions ● Record ADV for Canadian Dollar futures, up 42% to 125K ● FX options ADV grew 67% to 66K ●
Slide 5: Strong new client acquisition across retail and institutional
1Q 2025 Earnings Commentary - Unaudited Strong new client acquisition across both retail and institutional segments underscores the success of our strategic initiatives and the attractiveness of our diverse product offerings ● 1Q 2025 was a standout quarter for new client acquisition ○ Retail trader
Slide 6: Market signals remain strong in the current environment
1Q 2025 Earnings Commentary - Unaudited Market signals remain strong in the current environment While we have seen peak volume days, the level of trading has been consistently higher Annual Trading Days >30 Million Contracts ● 43% of trading days to date in 2025 (just under 4 months) have totaled >3
Slide 7: Financial Results, Notes & Guidance
1Q 2025 Earnings Commentary - Unaudited Financial Results ● 1Q25 revenue was $1.6 billion, up 10% versus ● On April 14, CME Group and S&P Global 1Q24. 1Q25 clearing and transaction fee announced a definitive agreement to sell revenue totaled $1.3 billion, up 11%, including OSTTRA to KKR, a leading g
Slide 8: Appendix - Micro Product Quarterly Details
1Q 2025 Earnings Commentary - Unaudited Financial Results Appendix - Micro Product Quarterly Details ADV in thousands / RPC in cents Micro Equity Index Products (including Micro Crypto) 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 ADV 2,725 2,099 2,169 2,250 2,336 2,487 2,945 2,486 3,502 RPC 27.8 31
Slide 9: Use of Non-GAAP Measures; Forward-Looking Statements
1Q 2025 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart within the financial statements posted on the Investor Relations page